175
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Exploring the allosteric mechanism of protein tyrosine phosphatase 1B by molecular dynamics simulations

, &
Pages 4040-4047 | Received 07 Jul 2019, Accepted 11 Sep 2019, Published online: 25 Oct 2019

References

  • Chen, J., Pang, L., Wang, W., Wang, L., Zhang, J. Z. H., & Zhu, T. (2019). Decoding molecular mechanism of inhibitor bindings to CDK2 using molecular dynamics simulations and binding free energy calculations. Journal of Biomolecular Structure and Dynamics, 1–12. doi:10.1080/07391102.2019.1591304
  • Chen, J., Wang, X., Pang, L., Zhang, J. Z. H., & Zhu, T. (2019). Effect of mutations on binding of ligands to guanine riboswitch probed by free energy perturbation and molecular dynamics simulations. Nucleic Acids Research, 47(13), 6618–6631. doi:10.1093/nar/gkz499
  • Choy, M. S., Li, Y., Machado, L. E. S. F., Kunze, M. B. A., Connors, C. R., Wei, X., … Peti, W. (2017). Conformational rigidity and protein dynamics at distinct timescales regulate PTP1B Activity and allostery. Molecular Cell, 65(4), 644–658. e645. doi:10.1016/j.molcel.2017.01.014
  • Hjortness, M. K., Riccardi, L., Hongdusit, A., Zwart, P. H., Sankaran, B., De Vivo, M., & Fox, J. M. (2018). Evolutionarily conserved allosteric communication in protein tyrosine phosphatases. Biochemistry, 57(45), 6443–6451. doi:10.1021/acs.biochem.8b00656
  • Hou, T., Li, N., Li, Y., & Wang, W. J. J. O P R. (2012). Characterization of domain–peptide interaction interface: prediction of SH3 domain-mediated protein–protein interaction network in yeast by generic structure-based models. 11(5), 2982–2995. doi:10.1021/pr3000688
  • Iversen, L. F., Andersen, H. S., Branner, S., Mortensen, S. B., Peters, G. H., Norris, K., … Møller, N. P. H. (2000). Structure-based design of a low molecular weight, nonphosphorus, nonpeptide, and highly selective inhibitor of protein-tyrosine phosphatase 1B. Journal of Biological Chemistry, 275(14), 10300–10307. doi:10.1074/jbc.275.14.10300
  • Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., … Wang, W. J. A. O C R. (2000). Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. 33(12), 889–897. doi:10.1021/ar000033j
  • Li, S., Zhang, J., Lu, S., Huang, W., Geng, L., Shen, Q., & Zhang, J. (2014). The mechanism of allosteric inhibition of protein tyrosine phosphatase 1B. PLoS One, 9(5), e97668. doi:10.1371/journal.pone.0097668
  • Onufriev, A., Bashford, D., & Case, D. A. J. P. S. (2004). Exploring protein native states and large‐scale conformational changes with a modified generalized born model. Function & Bioinformatics, 55(2), 383–394. doi:10.1002/prot.20033
  • Shao, J., Tanner, S. W., Thompson, N., & Cheatham, T. E. J. (2007). Clustering molecular dynamics trajectories: 1. Characterizing the performance of different clustering algorithms. Computation 3(6), 2312–2334. doi:10.1021/ct700119m
  • Sun, H., Li, Y., Shen, M., Tian, S., Xu, L., Pan, P., … Hou, T. (2014). Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA Rescorin. Journal of Physical Chemistry Chemical Physics, 16(40), 22035–22045. doi:10.1039/C4CP03179B
  • Sun, H., Li, Y., Tian, S., Xu, L., & Hou, T. J. P. C. C. P. (2014). Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data Set. Journal of Physical Chemistry Chemical Physics, 16(31), 16719–16729. doi:10.1039/C4CP01388C
  • Tonks, N. K., Diltz, C. D., & Fischer, E. H. (1988). Purification of the major protein-tyrosine-phosphatases of human placenta. Journal of Biological Chemistry, 263(14), 6722–6730.
  • Wiesmann, C., Barr, K. J., Kung, J., Zhu, J., Erlanson, D. A., Shen, W., … Hansen, S. K. (2004). Allosteric inhibition of protein tyrosine phosphatase 1B. Nature Structural & Molecular Biology, 11(8), 730–737. doi:10.1038/nsmb803
  • Zhang, Z. Y., & Lee, S. Y. (2003). PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity. Expert Opin Investig Drugs, 12(2), 223–233. doi:10.1517/13543784.12.2.223

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.